GlassScriptPhysician profile
Lindsey Seipp
NPI 1629664388
$3,247.29
in general payments reported to CMS, 2019-2025
31 companies · $862 in 2025
The $862 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.18 · 2022: $792 · 2023: $535 · 2024: $1,038 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,435.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $634.20 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $515.52 | 2022-2025 | |
| Pfizer INC. | $368.69 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $278.71 | 2022-2023 | |
| Novo Nordisk INC | $171.88 | 2022-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $164.12 | 2024-2025 | Trelegy Ellipta |
| Amgen INC. | $163.36 | 2022-2025 | Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $117.44 | 2022-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $116.17 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $100.55 | 2022-2023 | |
| Exact Sciences Corporation | $67.33 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $56.73 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Scilex Pharmaceuticals INC. | $51.28 | 2022-2023 | Ztlido |
| Sumitomo Pharma America, INC. | $49.49 | 2023-2024 | Gemtesa |
| Mylan Specialty L.P. | $46.10 | 2024 | Yupelri |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $34.25 | 2025 | Rexulti |
| Boston Scientific Corporation | $32.56 | 2024-2025 | Watchman Flx |
| Nevro Corp. | $29.17 | 2023 | Senza |
| Takeda Pharmaceuticals U.S.A., INC. | $26.34 | 2025 | Trintellix |
| Averitas Pharma INC. | $24.85 | 2023 | Qutenza |
| Electromed, INC. | $23.34 | 2022 | |
| Gilead Sciences, INC. | $23.03 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $20.96 | 2025 | Austedo Xr |
| Avanir Pharmaceuticals, INC. | $20.18 | 2021 | |
| Dexcom, INC. | $19.83 | 2023 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $18.10 | 2023 | Veozah |
| Baxter Healthcare | $17.67 | 2023 | Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $16.14 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.32 | 2023 | |
| Axsome Therapeutics, INC. | $14.04 | 2025 | Symbravo |
| Phathom Pharmaceuticals, INC. | $10.94 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Seipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.